People with cystic fibrosis, or CF, don’t appear to be especially susceptible to COVID-19, and when they do get infected, they don’t seem to get sicker, based on clinical data so far. But Ruobing (Ruby) Wang, an assistant professor of pediatrics at Harvard Medical School who cares for patients with CF at Boston Children’s Hospital, thinks … Continued
Grandparents tired of pandemic video calls are eager to hug grandchildren, and as seniors receive COVID-19 vaccinations, many want to know what their vaccination status means with regard to family and friends. Here are responses to some common questions.
A newly published study by Harvard Medical School investigators at the Ragon Institute of MGH, MIT, and Harvard and Massachusetts General Hospital sheds much-needed light on the drivers behind such different disease manifestations in both children and adults. The work, published Feb. 12 in Nature Medicine, indicates that specific types of antibodies may be driving these … Continued
Rolling out vaccines as quickly as possible and doubling down on COVID-19 precautions such as wearing masks will be the most effective tools to fight the virus in the months to come, according to Harvard Chan School’s Atul Gawande. In interviews with a variety of media outlets, Gawande, professor in the Department of Health Policy … Continued
A report from a new study led by Harvard Medical School investigators at the Ragon Institute, Massachusetts General Hospital, and Brigham and Women′s Hospital suggests that the mere presence of antibodies may not be sufficient to determine whether a person has built long-lasting protection following infection.
Harvard University researchers studying ways to reduce the risk of COVID-19 transmission during air travel endorsed the idea of rapid testing of passengers in a report released Thursday. “Viral testing is an important public health screening mechanism that can quickly and efficiently identify those with infections and stop them from undergoing activities that could expose … Continued
The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute’s eRapid technology with the company’s proprietary transistor sensor technology to enable simultaneous electrochemical sensing of … Continued
Harvard researchers recently discovered that a prior case of pneumonia can be a strong indicator that you’ll have a more severe—or even deadly—case if infected with COVID. In their new study, published in the journal NPJ Digital Medicine on Feb. 4, they pulled data from the medical records of nearly 17,000 COVID patients. Their research … Continued
What we learned about treating COVID-19 in year one of the pandemic. This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education, and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.
TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), announced the publication of a COVID-19 study using real-world data (RWD) from the company’s network. The research, conducted by Massachusetts General Hospital and Harvard Medical School and published in The Lancet Rheumatology, found that individuals … Continued